VP, Insights Sales (Brio)

Bionews, Inc.β€’Pensacola, FL
β€’Remote

About The Position

Bionews is diversifying beyond its core Digital DTC business into HCP, Insights, Clinical Recruitment, and direct pharma partnerships, and Insights is central to that growth. The VP, Insights Sales is a full-time, quota-carrying seller responsible for building and closing new business across Bionews' Insights portfolio, with a primary focus on launching and selling Brio, Bionews' new subscription-based rare disease market research platform, to pharma and biotech clients. Brio is the first patient research platform built inside real rare disease communities: consented, proprietary, and covering 16 conditions at launch in fall 2026. This role will own the go-to-market motion for Brio as a net-new subscription product, while also selling Bionews' broader Insights capabilities (custom research, patient advisory panels, surveys, and syndicated data) to medical affairs, market research, insights, and brand teams at pharma and biotech companies. This is a strategic, high-visibility hire reporting into Commercial Leadership, with significant influence over how Bionews positions and prices a brand-new product line in market. This role is designed to lead Insights and Brio new-business sales as the function scales alongside the company's evolving needs and strategic priorities. Brio launches in fall 2026; the initial months of this role will center on pipeline-building, early-adopter sales, and refining positioning and pricing in partnership with Product and Marketing, with quota and territory scope expanding as the platform matures.

Requirements

  • 8+ years of quota-carrying sales experience in pharma market research, insights, life sciences data, or SaaS platform sales, ideally selling into medical affairs, market research/insights, or brand teams, with a track record of operating at a senior, executive-facing level.
  • Demonstrated understanding of how pharma and biotech companies evaluate and procure market research and patient insights solutions.
  • Consistent track record of meeting or exceeding sales quotas, with strong pipeline and forecast discipline.
  • Comfort and creativity selling a brand-new, subscription-based platform into a market with entrenched vendors, including shaping positioning as it evolves.
  • Exceptional written and verbal communication skills, with the ability to run compelling platform demos and executive-level conversations.

Nice To Haves

  • Genuine interest in and alignment with the rare disease community and Bionews' patient-centered mission.

Responsibilities

  • Identify and prioritize target accounts across pharma and biotech medical affairs, market research/insights, and brand teams for the fall 2026 launch.
  • Run discovery calls, platform demos, and proposal development to convert prospects into Brio subscribers across the 16 launch conditions.
  • Close new subscription agreements and manage the full sales cycle from first outreach through contract signature and onboarding handoff.
  • Partner with the Insights/Brio product team on packaging, pricing, and positioning based on live market feedback.
  • Sell Bionews' broader Insights offerings, including custom market research, patient advisory panels, surveys, and syndicated data, to complement Brio and expand wallet share within accounts.
  • Build and maintain a qualified pipeline sufficient to meet quarterly and annual revenue targets for the Insights line of business.
  • Identify opportunities to bundle Insights/Brio into broader Bionews pharma partnerships alongside DTC, HCP, and Clinical Recruitment.
  • Maintain accurate, current Salesforce records for all opportunities, activities, and forecasts.
  • Provide reliable weekly and monthly forecasts to Commercial Leadership, flagging risk and acceleration opportunities early.
  • Serve as the primary point of contact for Brio and Insights clients from first conversation through renewal, ensuring a strong client experience that supports retention and expansion.
  • Bring the patient voice into every pitch. Bionews' key differentiator is the ability to bring real patients directly into client conversations so lived experience shapes strategy and messaging.
  • Track the competitive landscape for rare disease market research and patient insights platforms, and share intelligence that sharpens Bionews' positioning.
  • Represent Bionews Insights and Brio at relevant industry conferences and events to build market awareness ahead of and following launch.
Β© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service